Last Week’s Hot Topic on Cystic Fibrosis

admin avatar

by admin |

Share this article:

Share article via email

news_9-21

Last week’s hot topic on Cystic Fibrosis titled Cystic Fibrosis Compound to Stabilize CFTR Protein Advances in Clinical Study was written by Daniela Semedo.

The article focuses on Nivalis Therapeutics, Inc., recently announcing an expanded clinical development plan for N91115, the company’s first-in-class stabilizer of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, which is defective in patients with cystic fibrosis (CF).

Read more articles about cystic fibrosis here: http://bit.ly/1jNDqsz


Featured Column

How I Discovered That PTSD Was Causing My Post-transplant Struggles

PTSD, mental health, communities, stress, grateful, work, trauma, rare disease day, transplant, CF community, National Blood Donor Month, birthdays, holidays
Columnist Lara Govendo addresses an issue that several readers may relate to: post-transplant PTSD, which can wreak havoc.

Read the Column


Your CF Community


Visit the Cystic Fibrosis News Today forums to connect with others in the CF community.